6609 — Shanghai HeartCare Medical Technology Share News
0.000.00%
- HK$2.05bn
- HK$1.17bn
- CNY408.29m
China's HeartCare Medical H1 revenue surges on stroke segment growth
Brief: Shanghai Heartcare Medical Technology Expects HY Revenue Of No Less Than Rmb280 Million
Brief: Shanghai Heartcare Medical Technology Approves H Share Repurchase Plan Up To HKD100 Million For Up To 1 Million H Shares
Brief: Shanghai HeartCare Medical Technology Sees FY PBT RMB80 Million
Brief: Shanghai Heartcare Medical Technology's Registration Application Accepted For Intracranial Drug-Eluting Stent
Brief: Shanghai Heartcare Medical Technology To Allot And Issue 1 Million Domestic Shares At HK$45.00 Per Share
Brief: Shanghai Heartcare Medical Technology Corp Expects HY Net Profit
Brief: Shanghai Heartcare Medical Technology Corp Announces Disposal Of Equity Interest
Brief: Shanghai Heartcare Medical Technology Says FY Loss Attributable RMB200.4 Million
Brief: Shanghai Heartcare Medical Technology To Apply For Issue Of Not More Than 13 Mln A Shares
Brief: Shanghai Heartcare Medical Technology Posts HY Revenue RMB76.7 Million
Brief: Shanghai Heartcare Medical Technology Corp Got Approval From NMPA For Registration Application For LAA Occluder
Brief: Shanghai Heartcare Medical Technology Got Approvals From Nmpa Of PRC For Registration Applications For Aspiration Catheter & Support Catheter
Brief: Shanghai Heartcare Medical Technology Says Wei Jiawei Nominated As An Executive Director
Brief: Shanghai Heartcare Medical Technology Posts FY Net Loss Attributable Of RMB197.9 Million
Brief: Shanghai Heartcare Medical Technology Corp Reports FY Revenue RMB90.1 Mln
Brief: Shanghai Heartcare Medical Technology Says U.S. FDA Granted Section 510K Clearance To Supselektm Microcatheter
Brief: Shanghai Heartcare Medical Technology Says Weiqi Medical Agreed To Buy 36% Stake In Iasocardiac Medical Technology
Brief: Shanghai Heartcare Medical Technology Says Trustee Purchased 55,000 Shares On Market